Skip to main content
Explore links (header)
  • UCLA Health Home
  • About Us
  • Cancer Center
  • Hospitals & Clinics
  • School of Medicine
  • Academic Departments
Universal links (header)
myUCLAhealth
News & Insights
Community & Equity
Contact Us
310-825-2631
  • English
  • العربية
  • 中文
  • Italiano
  • 日本語
  • 한국어
  • فارسی
  • Русский
  • Español
  • Tiếng Việt
  • English
  • العربية
  • 中文
  • Italiano
  • 日本語
  • 한국어
  • فارسی
  • Русский
  • Español
  • Tiếng Việt
Search
Try looking up a doctor, a clinic location, or information about a condition/treatment.
Examples
  • "Lin Chang" for a Doctor by name
  • "Flu Symptoms" for a Condition
  • "Cardiologist" for a Doctor by specialty
  • "Santa Monica" for a Location
UCLA Health
Primary navigation
  • Find a Doctor
  • Find a Location
  • Virtual Care
  • Make an Appointment
  • Second Opinion Consults
  • Medical Services
  • Cancer Medical Services
  • Outpatient Locations
  • Prepare for Your Visit
  • Visitor Guidelines
  • Billing & Insurance
  • Medical Records
  • Community Resources
  • Support & Information
  • Patient Financial Assistance Program
  • International Services
  • Medical Services
  • Wellness & Routine Care
  • Clinical Trials
  • COVID-19 Info
  • Immediate Care
  • Primary Care
  • Pediatric Care
  • Cancer Care
  • Surgical Centers
  • Imaging/Radiology
  • Hospitals
  • All Locations
  • About UCLA Health
  • Patient Stories
  • Events Calendar
  • Donate to UCLA Health
  • Work at UCLA Health
  • For Healthcare Professionals
  • Connect with UCLA Health
  • Care Compliments
Find a Doctor
Primary navigation (mobile)
Find a Doctor
  • Find a Doctor
  • Find a Location
  • Virtual Care
  • Make an Appointment
  • Second Opinion Consults
  • Medical Services
  • Cancer Medical Services
  • Outpatient Locations
  • Prepare for Your Visit
  • Visitor Guidelines
  • Billing & Insurance
  • Medical Records
  • Community Resources
  • Support & Information
  • Patient Financial Assistance Program
  • International Services
  • Medical Services
  • Wellness & Routine Care
  • Clinical Trials
  • COVID-19 Info
  • Immediate Care
  • Primary Care
  • Pediatric Care
  • Cancer Care
  • Surgical Centers
  • Imaging/Radiology
  • Hospitals
  • All Locations
  • About UCLA Health
  • Patient Stories
  • Events Calendar
  • Donate to UCLA Health
  • Work at UCLA Health
  • For Healthcare Professionals
  • Connect with UCLA Health
  • Care Compliments
Explore links (mobile)
  • UCLA Health Home
  • About Us
  • Cancer Center
  • Hospitals & Clinics
  • School of Medicine
  • Academic Departments
Universal links (mobile)
myUCLAhealth
News & Insights
Community & Equity
Contact Us
310-825-2631
Breadcrumb
  1. Home
  2. Departments
  3. Radiology
  4. Education
  5. Breast Imaging Teaching Resources
  6. BIRADS
Radiology

Architectural Distortion

Sub-navigation

BIRADS
  • Mammography: Breast Composition: The Impact of Dense Breasts
  • Mammography: Masses
  • Mammography: Calcifications
  • Mammography: Architectural Distortion
  • Mammography: Breast Asymmetry
  • Ultrasound: Associated Features
  • Ultrasound: Basics of Breast Ultrasound
  • Ultrasound: Calcifications
  • Ultrasound: Masses
  • Breast MRI Indications
  • MRI Sequences and How to Read a Breast MRI and BI-RADS
  • Breast MRI Findings: Breast Implant
  • Breast MRI Findings: Focus and Mass
  • Breast MRI Findings: Kinetics
  • Breast MRI Findings: Non Mass Enhancement (NME)
  • Breast MRI Findings: Post-Surgical Findings
BIRADS
  • Mammography: Breast Composition: The Impact of Dense Breasts
  • Mammography: Masses
  • Mammography: Calcifications
  • Mammography: Architectural Distortion
  • Mammography: Breast Asymmetry
  • Ultrasound: Associated Features
  • Ultrasound: Basics of Breast Ultrasound
  • Ultrasound: Calcifications
  • Ultrasound: Masses
  • Breast MRI Indications
  • MRI Sequences and How to Read a Breast MRI and BI-RADS
  • Breast MRI Findings: Breast Implant
  • Breast MRI Findings: Focus and Mass
  • Breast MRI Findings: Kinetics
  • Breast MRI Findings: Non Mass Enhancement (NME)
  • Breast MRI Findings: Post-Surgical Findings

by Ashley Yeager, MD, Lucy Chow, MD, and Bo Li, MD

Definitions

Architectural distortion is a descriptive term used by radiologists to describe a particular mammogram finding related to the appearance of the breast tissue. The Breast Imaging Reporting and Data System (BI-RADS) is a tool which sets guidelines for radiologists to assess the risk of various breast findings. This system defines architectural distortion as breast parenchyma that is “distorted with no definite mass visible. This includes spiculations radiating from a point and focal retraction or distortion at the edge of the parenchyma.”1

Craniocaudal mammogram view showing an architectural distortion within the lateral right breast (red circle). Note the irregular radiating lines from a central focal region compared to the surrounding normal breast parenchyma.
Figure 1: Craniocaudal mammogram view showing an architectural distortion within the lateral right breast (red circle). Note the irregular radiating lines from a central focal region compared to the surrounding normal breast parenchyma.

Figure 1 shows a classic mammogram appearance of architectural distortion. As denoted by the red circle, abnormal, fine tissue lines can be seen emanating in a radial pattern and appear to originate from a central focal region. This is in contrast to the surrounding normal parenchymal breast tissue which does not follow this irregular radial pattern. Architectural distortions may be present with no additional mammogram findings (as seen in Figure 1) or in association with other findings such as calcifications or dense masses.

When initially found on 2D digital screening mammogram, additional mammographic imaging with tomosynthesis including with spot-compression is warranted. Several studies have shown that detection of architectural distortion improves with tomosynthesis2,3 by allowing visualization of the breast in thin, sequential sections. Visualizing a lesion of interest as multiple sequential planes can help the radiologist rule out the possibility that the lesion merely represents superimposition of overlapping normal breast tissue which occurs commonly when a 3-dimensional tissue is represented as a 2-dimensional image.2

Additional spot compression views of the architectural distortion seen on craniocaudal mammogram view shows persistence of the architectural distortion within the lateral right breast (red circle). This appearance is consistent with a real distortion of the breast parenchyma and not simply overlapping normal fibroglandular tissue.
Figure 2: Additional spot compression views of the architectural distortion seen on craniocaudal mammogram view shows persistence of the architectural distortion within the lateral right breast (red circle). This appearance is consistent with a real disto

Figure 2 shows spot compression tomosynthesis of the architectural distortion shown in Figure 1. Note how the region of architectural distortion does not appear to “smooth out”, but rather retains a fairly stable appearance compared to Figure 1.

Architectural distortion often represents a diagnostic challenge as it can be a subtle finding and has been reported as the most commonly missed abnormality on traditional 2D digital screening mammograms.4 The advent of 3D tomosynthesis has improved the detection of architectural distortion compared to traditional 2D mammographic views,5 however, this increased detection rate has also translated to an increased false positive rate and a reported positive predictive value for malignancy of just over 50%.5

Causes

Architectural distortion can be caused by both benign and malignant entities. Shaheen et al. recently classified architectural distortions based on their causality and categorized these into groups termed “Apparent,” “Primary” or “Secondary”. Apparent architectural distortions are those distortions that do not persist with additional mammogram views and represent the overlap of normal breast tissue.6

Primary architectural distortions include lesions that arise within the breast de novo without an identifiable cause. These lesions include: both malignant and benign primary breast cancers, fibrosis and radial sclerosing lesions, sclerosing adenosis, and mesenchymal neoplasms arising from mammary stroma tissues.6

Secondary architectural distortions are lesions which arise due to causes that are known to distort breast tissues. The most common entities include those tissue changes which occur following breast surgeries such as lumpectomy/excision or cosmetic surgeries such as reduction mammoplasty, as well as known traumatic injuries to the breast and changes associated with some breast infections.6

Architectural distortions often do not have a sonographic correlate. However, recent advances in sonography have allowed some researchers to correlate some malignancy-associated architectural distortions with key sonographic findings. Takei et al. recently reported ultrasound findings correlating with architectural distortions. Findings included retraction of surrounding breast tissue adjacent a malignancy, the actual malignancy itself, tumor spreading into the Cooper ligaments of the breast, and fibrosis caused by contraction of breast tissue following chemotherapy.7

Management

The malignancy risk associated with architectural distortion varies widely within the literature and researchers have reported positive predictive values ranging from 10%8 to over 50%5 when found by digital breast tomosynthesis. Architectural distortion is considered a high risk entity and has been reported to represent the third most common finding of non-palpable breast cancers.9

Architectural distortions associated with other findings, such as a distinct mass-like lesion or calcifications, are typically considered higher risk regardless of whether the additional finding was seen by ultrasound or mammography. Several researchers have reported a nearly 3-fold malignancy risk for architectural distortions that have an associated sonographic finding compared to those without a sonographic correlate.10,11 These are commonly referred for biopsy via stereotactic-guided mammogram or ultrasound with pathological outcomes dictating surgical management.

Architectural distortions with no sonographic correlate or additional mammogram findings can be challenging. Architectural distortion without an associated mass finding is seen more commonly in association with a malignant cause compared to a benign cause.12 Given the relatively high association of architectural distortion with malignant causes, many radiologists will recommend a biopsy and possibly additional surgical management even for those lesions which return as benign entities. This can lead to increased patient morbidity from unnecessary surgical interventions.

Several studies have explored the use of breast MRI to manage architectural distortions when no other associated mammogram or ultrasound findings can be seen. Amitai et al. recently showed that in cases with no sonographic or associated mammogram findings, the negative predictive value for breast MRI reached nearly 100% and authors argued that special cases of architectural distortion with a negative breast MRI could be followed by imaging alone without the need for surgical intervention.13

References

  1. D’Orsi, C., Sickles, E., Mendelson, E. & Morris, E. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. (Reston, VA, American College of Radiology, 2013). https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-RadsLink is external(Link is external) (Link opens in new window)
  2. Partyka, L., Lourenco, A. P. & Mainiero, M. B. “Detection of Mammographically Occult Architectural Distortion on Digital Breast Tomosynthesis Screening: Initial Clinical Experience.” Am. J. Roentgenol. 203, 216–222 (2014). DOI: 10.2214/AJR.13.11047Link is external(Link is external) (Link opens in new window)
  3. Yang, T.-L., Liang, H.-L., Chou, C.-P., Huang, J.-S. & Pan, H.-B. “The adjunctive digital breast tomosynthesis in diagnosis of breast cancer.” BioMed Res. Int. 2013, 597253 (2013). DOI: 10.1155/2013/597253Link is external(Link is external) (Link opens in new window)
  4. Burrell, H. C. et al. “Screening interval breast cancers: mammographic features and prognosis factors.” Radiology 199, 811–817 (1996). DOI: 10.1148/radiology.199.3.8638010Link is external(Link is external) (Link opens in new window)
  5. Bahl, M., Lamb, L. R. & Lehman, C. D. “Pathologic Outcomes of Architectural Distortion on Digital 2D Versus Tomosynthesis Mammography.” AJR Am. J. Roentgenol. 209, 1162–1167 (2017). DOI: 10.2214/AJR.17.17979Link is external(Link is external) (Link opens in new window)
  6. Shaheen, R., Schimmelpenninck, C. A., Stoddart, L., Raymond, H. & Slanetz, P. J. “Spectrum of diseases presenting as architectural distortion on mammography: multimodality radiologic imaging with pathologic correlation.” Semin. Ultrasound. CT MR 32, 351–362 (2011). DOI: 10.1053/j.sult.2011.03.008Link is external(Link is external) (Link opens in new window)
  7. Takei, J. et al. “Clinical implications of architectural distortion visualized by breast ultrasonography.” Breast Cancer Tokyo Jpn. 16, 132–135 (2009). DOI: 10.1007/s12282-008-0085-5Link is external(Link is external) (Link opens in new window)
  8. Alshafeiy, T. I. et al. “Outcome of Architectural Distortion Detected Only at Breast Tomosynthesis versus 2D Mammography.” Radiology 288, 38–46 (2018). DOI: 10.1148/radiol.2018171159Link is external(Link is external) (Link opens in new window)
  9. Gaur, S., Dialani, V., Slanetz, P. J. & Eisenberg, R. L. “Architectural distortion of the breast.” AJR Am. J. Roentgenol. 201, W662-670 (2013). DOI: 10.2214/AJR.12.10153Link is external(Link is external) (Link opens in new window)
  10. Bahl, M., Baker, J. A., Kinsey, E. N. & Ghate, S. V. “Architectural Distortion on Mammography: Correlation With Pathologic Outcomes and Predictors of Malignancy.” AJR Am. J. Roentgenol. 205, 1339–1345 (2015). DOI: 10.2214/AJR.15.14628Link is external(Link is external) (Link opens in new window)
  11. Dou, E., Ksepka, M., Dodelzon, K., Shingala, P. Y. & Katzen, J. T. “Assessing the Positive Predictive Value of Architectural Distortion Detected with Digital Breast Tomosynthesis in BI-RADS 4 Cases.” J. Breast Imaging 2, 552–560 (2020). DOI: 10.1093/jbi/wbaa078Link is external(Link is external) (Link opens in new window)
  12. Park, J. W., Ko, K. H., Kim, E.-K., Kuzmiak, C. M. & Jung, H. K. “Non-mass breast lesions on ultrasound: final outcomes and predictors of malignancy.” Acta Radiol. Stockh. Swed. 1987 58, 1054–1060 (2017). DOI: 10.1177/0284185116683574Link is external(Link is external) (Link opens in new window)
  13. Amitai, Y. et al. “Can breast MRI accurately exclude malignancy in mammographic architectural distortion?” Eur. Radiol. 30, 2751–2760 (2020). DOI: 10.1007/s00330-019-06586-xLink is external(Link is external) (Link opens in new window)
UCLA Health
International Services
Regional Sites
  • 中文 |
  • العربية

Footer Utility links

  • myUCLAhealth
  • Community & Equity
  • News & Insights
  • Your Feedback
  • Contact Us

Footer navigation

  • Find Care

    • Find a Doctor
    • Find a Location
    • Immediate Care
    • Emergency Care
    • Make an Appointment
    • Medical Services
  • Patient Resources

    • Prepare for Your Visit
    • Visitor Guidelines
    • Patient Education
    • Billing & Insurance
    • Price Transparency
    • Support & Information
  • Treatment Options

    • COVID-19 Info
    • Wellness & Routine Care
    • Clinical Trials
  • Discover UCLA Health

    • About UCLA Health
    • Departments
    • Patient Stories
    • For Healthcare Professionals
    • Inclusive Excellence
    • Contact Media Team
    • Donate to UCLA Health
    • Work at UCLA Health
    • Volunteer for UCLA Health
    • Share Your Experience
    • Subscribe to our Newsletter
    • Read our Publications
  • Get the UCLA Health App

    • Download on the App Store
    • Get it on Google Play
    • View all UCLA Health Apps

Policy links (footer)

    |
  • HIPAA Notice |
  • Privacy Notice |
  • Nondiscrimination |
  • Report Misconduct |
  • We listen. We care.
© 2025 UCLA Health